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CASE REPORT
Plasmodium falciparum and Mycoplasma 
pneumoniae co-infection presenting 
with cerebral malaria manifesting orofacial 
dyskinesia and haemophagocytic 
lymphohistiocytosis
Praveen Weeratunga1, Gowri Rathnayake1, Ahalya Sivashangar1, Panduka Karunanayake1,2, 
Ariaranee Gnanathasan1,2 and Thashi Chang1,2*
Abstract 
Background: Malaria is a mosquito-borne infectious disease with diverse clinical manifestations caused by a parasitic 
protozoan of the genus Plasmodium. Complex inter-relationships between Mycoplasma species and Plasmodium 
parasites have been previously noted in vitro. This is the first report of Plasmodium falciparum and Mycoplasma 
pneumoniae co-infection in a human host presenting with cerebral malaria manifesting orofacial dyskinesias and 
haemophagocytic lymphohistiocytosis.
Case presentation: A 55-year-old Sri Lankan man with a recent visit to South Africa presented with an acute febrile 
illness, cough and worsening dyspnoea with alveolar-interstitial infiltrates on chest radiography. Serological evalu-
ation confirmed a diagnosis of Mycoplasma infection. He subsequently developed encephalopathy with orofacial 
dyskinesia. A diagnosis of severe P. falciparum infection with significant parasitaemia was established. Peripheral blood 
cytopaenia occurred due to haemophagocytic lymphohistiocytosis in the bone marrow. Complete clinical and hae-
matological recovery was achieved with intravenous artesunate.
Conclusions: Plasmodium falciparum and Mycoplasma pneumoniae co-infection occurring in vivo manifests clinical 
features that are plausibly a result of the interaction between the two microorganisms. This is the first report of orofa-
cial dyskinesia in either infection.
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Background
Malaria is caused by protozoa of the genus Plasmo-
dium, of which five species are known to cause human 
disease; it is transmitted by Anopheles spp. mosquitoes. 
The clinical manifestations range from uncomplicated 
infection to severe multisystem affliction with signifi-
cant mortality. Plasmodium falciparum infections have 
a high predilection of multisystem manifestations. This 
case report highlights the unusual combination of Myco-
plasma and P. falciparum co-infection presenting with 
cerebral malaria manifesting orofacial dyskinesias and 
haemophagocytic lymphohistiocytosis.
Case presentation
A 55-year-old Sri Lankan man employed as a chef in 
Dubai, United Arab Emirates, presented to the National 
Hospital of Sri Lanka with fever for five days and asso-
ciated headache, arthralgia, myalgia and severe prostra-
tion approximately 3  weeks after spending 2  months in 
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South Africa as part of his employment. He had been 
previously well and had not been on chemoprophylaxis 
for malaria while in South Africa. He has had a worsen-
ing non-productive cough and shortness of breath 1 day 
prior to presentation. On examination, he was pale and 
had posterior cervical lymphadenopathy. His respiratory 
rate was 30 cycles/min and he had bilateral diffuse scat-
tered crepitations and rhonchi in both lung bases. Rest of 
the systems examination was normal.
Initial investigations revealed a marginal neutro-
phil predominance with thrombocytopaenia (plate-
lets—55,000/mm3) and the chest radiograph showed 
alveolar-interstitial shadowing. The patient was empiri-
cally treated with clarithromycin for 7  days, which 
resulted in the resolution of the chest symptoms and 
signs, but with poor resolution of fever. His serum Myco-
plasma IgM ELISA (Sigma Aldrich) antibody titre was 
strongly positive at a dilution of 1/1260 with a repeat titre 
noted at 1/7560, four weeks after the initial presentation. 
Given the recent travel history, a blood film was examined 
for evidence of malaria, but was noted to be negative. 
Despite initial improvement, progressive thrombocyto-
penia and worsening anaemia were noted from day 7 of 
his illness. By day 10, his level of consciousness deterio-
rated demonstrating abnormal behaviour and worsening 
drowsiness. Frequent, stereotyped, intermittent orofa-
cial dyskinetic movements, not attributable to any of the 
drugs administered, were noted (see Additional file  1). 
Magnetic resonance imaging of the brain was normal. A 
blood film done at this time demonstrated multiple ring 
forms of P. falciparum with a parasite load of 300,000/μl. 
Intravenous artesunate was commenced and the patient 
demonstrated remarkable clinical improvement with 
resolution of abnormal movements and improvement of 
level of consciousness within 24 h. The high-spiking fever 
which was persistent up to day 12 of illness resolved. 
However a further decline in the platelet count was 
noted up to day 14 and a fall in the haemoglobin to 7 g/
dl. His fasting triglyceride level was 405 mg/dl, serum fer-
ritin 25,000  ng/ml and lactate dehydrogenase 1600  U/l. 
His INR was 1.7; APTT 41s; and fibrinogen level 1.1 g/l. 
Ultrasound scan of the abdomen demonstrated hepato-
splenomegaly. Bone marrow examination demonstrated 
evidence of resolving haemophagocytosis.
These haematological manifestations subsequently 
resolved within the next 72  h and the patient made a 
complete clinical recovery.
Conclusions
This patient highlights a rare combination of a dual-
infection manifesting as a biphasic illness with clini-
cal characteristics inherent to each microorganism. The 
initial presentation was of an acute febrile illness with 
predominant respiratory involvement and thrombocyto-
paenia with chest radiography demonstrating interstitial 
lung inflammation associated with serological confirma-
tion of Mycoplasma infection. The subsequent phase was 
of worsening peripheral blood cytopaenia and neurologi-
cal manifestations despite resolution of respiratory fea-
tures caused by severe P. falciparum infection.
Complex inter-relationships between Mycoplasma 
species and Plasmodium parasites have been previously 
noted in vitro and in animal models [1, 2]. The effects of 
other microbial agents provoking host stress response to 
activate latent pathogenic Mycoplasma have been inves-
tigated in animal studies [1]. Accelerated growth of con-
taminant Mycoplasma species in cultures of P. falciparum 
had resulted in subsequent reduction in Plasmodium 
parasitaemia [2]. This is the first report of P. falciparum 
malaria and Mycoplasma co-infection in a human host. 
It is plausible that this patient acquired latent infections 
of both organisms in South Africa and the eradication of 
Mycoplasma may have led to a surge of P. falciparum par-
asitaemia, which had been suppressed by Mycoplasma, 
predisposing the patient to develop cerebral malaria. 
The incubation period for presentation in this patient 
is unusually long for P. falciparum malaria. The authors 
hypothesize that this long incubation period may be due 
to the suppression of P. falciparum parasitaemia due to 
Mycoplasma coinfection. It is extremely unlikely that he 
could have acquired the infection in Sri Lanka as the last 
endemic case was reported in October 2012.
The cerebral manifestations of P. falciparum infec-
tion are diverse, ranging from encephalopathy, seizures, 
dysconjugate ocular movements to psychiatric mani-
festations and post-malaria neurological syndromes [3]. 
However orofacial dyskinesias as observed in this patient 
have not been previously documented in malaria. Simi-
larly, although neurological manifestations such as chore-
oathetosis have been reported in Mycoplasma infection 
[4], orofacial dyskinesia has not been described. It is 
plausible that the complex interaction between the two 
organisms may have predisposed to this atypical neuro-
logical manifestation, which is clinically significant since 
orofacial dyskinesia has been increasingly recognized to 
characteristically occur in NMDAR-antibody encephali-
tis [5, 6] and this case description adds to its differential 
diagnosis of a comatose patient presenting with move-
ment disorders, particularly in the orofacial region.
The progressive cytopaenia in this patient was attrib-
uted to haemophagocytic lymphohistiocytosis (HLH). 
Although severe malaria per se can cause cytopaenia, 
HLH was considered more likely in this patient because 
the cytopaenia developed during the resolution phase of 
malaria and was associated with hypofibrinogenaemia, 
hyperferritinaemia, hypertriglyceridaemia and a high 
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index of haemophagocytosis in the bone marrow. HLH 
has been previously reported with both Mycoplasma and 
malaria [7, 8]. Although other cytokine markers were 
not tested due to unavailability, this patient fulfilled the 
standard diagnostic criteria for HLH.
This is the first report of human P. falciparum and 
Mycoplasma pneumoniae co-infection manifesting clini-
cal features that are plausibly a result of the interaction 
between the two microorganisms. It is also the first 
report of orofacial dyskinesia in either disease.
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